Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03008408
Title Phase II Ribociclib, Everolimus and Letrozole in Endometrial Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

endometrial carcinoma

Therapies

Everolimus + Letrozole + Ribociclib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.